FDL169

FTIH - Single and Repeat Oral Doses of FDL169 in Healthy Volunteers

Pharmacokinetics of FDL169 in Healthy Female Subjects

Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects

An Phase 1 Study to Evaluate the Pharmacokinetic (PK) Profile of FDL169 New Formulations in Healthy Subjects

A Study to Compare the Pharmacokinetics of Different Oral Formulations of FDL169 in Healthy Subjects

A DDI Study of FDL169 and FDL176 in Healthy Subjects